LAPOINTE, BLAIR T.,FULLER, PETER H.,GUNAYDIN, HAKAN,LIU, KUN,SCOTT, MARK E.,TROTTER, B. WESLEY,ZHANG, HONGJUN
申请号：
CA3002850
公开号：
CA3002850A1
申请日:
2016.10.27
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention relates to compounds according to Formula (I) and pharmaceutically acceptable salts thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
